COMBINATION OF NOREPINEPHRINE REUPTAKE INHIBITOR AND A CANNABINOID FOR USE IN TREATING SLEEP APNEA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240189328A1
SERIAL NO

18286399

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pharmaceutical compositions comprising a norepinephrine reuptake inhibitor (NRI) and a cannabinoid and optionally a muscarinic receptor antagonist (MRA) and/or carbonic anhydrase inhibitor (CAI) and methods of treating sleep apnea are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APNIMED INC (DELAWARE)39 JOHN F KENNEDY STREET 4TH FLOOR CAMBRIDGE MA 02138

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FARKAS, Ronald Clarksville, US 12 0
MILLER, Lawrence G Cambridge, US 25 565
TARANTO-MONTEMURRO, Luigi Brookline, US 13 3
WHITE, David P Denver, US 7 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation